🍂 Enjoy the Fall Season! 🍂
MindTheDesk

J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion

Business • November 16, 2026 • 3 views
J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion
Johnson & Johnson said it would acquire Ollin for $2.2 billion upfront, with ​the potential for milestone ​payments of up to about $1.13 billion.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"We build AI or anything ICST"
"Camping the Easyway"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Output is a realization of Input."